Additional file 3: of A robust prognostic gene expression signature for early stage lung adenocarcinoma

TCGA LUSC clinical data. (TXT 124 kb

Additional file 1: Figure S1A. of A robust prognostic gene expression signature for early stage lung adenocarcinoma

TCGA LUAD RNAseq − stage I and II ESLA − 7, DFS. Figure S1B: TCGA LUAD RNAseq − stage I and II ESLA − 7, DFS − no treatment. Figure S1C: TCGA LUAD RNAseq − stage I and II CIN25, DFS. Figure S1D: TCGA LUAD RNAseq − stage I and II CIN25, DFS − no treatment. Figure S1E: TCGA LUAD RNAseq − stage I and II CCP, DFS. Figure S1F: TCGA LUAD RNAseq − stage I and II CCP, DFS − no treatment. (PDF 20 kb

Additional file 3: of TumorTracer: a method to identify the tissue of origin from the somatic mutations of a tumor specimen

Table comparing TumorTracer to ICOMS. (DOCX 14 kb

Additional file 1: of TumorTracer: a method to identify the tissue of origin from the somatic mutations of a tumor specimen

Contains Supplementary Figs. 1–3. (PDF 547 kb